In the Press - Vivaldi - The Outstanding Society

In the Press/Publications

29th April 2024

Loveday & Co

Loveday Abbey Road Enhances Care with VIVALDI

Loveday Abbey Road is delighted to participate in the VIVALDI Social Care pilot scheme, which was commissioned by the UK Health Security Agency during the pandemic to monitor infections in care homes.

30th January 2024

Dept Health & Social Care

Infection Prevention and Control (IPC) Champion Network Meeting

Chair: Charlotte Fry, RN, DN, QN, Expert Lead Nurse, IPC Champions Network

5th December 2023

Journal of the American Medical Directors Association.

Built Environment and SARS-CoV-2 Transmission in Long Term Care Facilities: Cross Sectional Survey and Data Linkage

Authors: Krutikov M, Stirrup O, Fuller C, Altamirano H, Copas A, … Shallcross L

4th December 2023

Wellcome Open Research

VIVALDI Cohort Profile: Using linked, routinely collected data and longitudinal blood sampling to characterise COVID-19 infections, vaccinations, and related outcomes in care home staff and residents in England

Krutikov M, Bone D, Stirrup O, Bruton R, Azmi B, … Shallcross L

8th November 2023

Journal of Hospital Infection

COVID-19-related mortality and hospital admissions in the VIVALDI study cohort: October 2020 to March 2023

Stirrup O, Krutikov M, Azmi B, Monakhov I, Hayward A, Copas A, Shallcross L

31st October 2023

AGETECH World

UKHSA launches new pilot to prevent care home infections

31st October 2023

Care Home Professional

New UK Health Security Agency scheme to target infections in care homes

30th October 2023

News Medical Life Sciences

UKHSA announces pilot scheme to monitor infections in care homes in England

30th October 2023

Care Management Matters

Pilot scheme to monitor infections announced

30th October 2023

UCL

Care home network aims to reduce infections

24th October 2023

BMJ Open

Shaping care home COVID-19 testing policy: a protocol for a pragmatic cluster randomised controlled trial of asymptomatic testing compared with standard care in care home staff (VIVALDI-CT)

Adams N, Stirrup O, Blackstone J, Krutikov M, Cassell J, … Shallcross L

8th August 2023

Age and Ageing

Effectiveness of successive booster vaccine doses against SARS-CoV-2 related mortality in residents of long-term care facilities in the VIVALDI study

Stirrup O, Shrotri M, Adams N, Krutikov M, Azmi B, … Shallcross L

20th January 2023

Nature Aging

Strong peak immunogenicity but rapid antibody waning following third vaccine dose in older residents of care homes

Tut G, Lancaster T, Krutikov M, Sylla P, Bone D, Spalkova E, … Moss P

1st January 2023

Open Forum Infectious Diseases

Clinical effectiveness of SARS-CoV-2 booster vaccine against Omicron infection in residents and staff of Long-Term Care Facilities: a prospective cohort study (VIVALDI)

Stirrup O, Shrotri M, Adams N, Krutikov M, Nacer-Laidi H, Azmi B, … & Shallcross L

1st July 2022

The Lancet Healthy Longevity

Antibody and cellular immune responses following dual COVID-19 vaccination within infection-naïve residents of long-term care facilities: an observational cohort study

Tut, G., Lancaster, T., Butler, M., Bone, D., Kaur, N., Spalkova, E., … & Moss, P

1st July 2022

The Lancet Healthy Longevity

Duration of vaccine effectiveness against SARS-CoV2 infection, hospitalisation, and death in residents and staff of Long-Term Care Facilities (VIVALDI): a prospective cohort study

Shrotri M, Krutikov M, Nacer-Laidi H, Azmi B, Palmer T, .. & Shallcross L

30th May 2022

Nature Aging

Robust SARS-CoV-2-specific and heterologous immune responses after natural infection in elderly residents of Long-Term Care Facilities

Tut G., Lancaster T., Butler M., Sylla P., Spalkova E., Bone D., … & Moss P

16th April 2022

Journal of Infectious Diseases

SARS-CoV-2 anti-spike antibody levels following second dose of ChAdOx1 nCov-19 or BNT162b2 in residents of long-term care facilities in England (VIVALDI)

Stirrup, O., Krutikov, M., Tut, G., Palmer, T., Bone, D., Bruton, R., … & Shallcross, L

1st March 2022

The Lancet Healthy Longevity

Outcomes of SARS-CoV-2 Omicron infection in residents of long-term care facilities in England (VIVALDI): a prospective, cohort study

Krutikov, M., Stirrup, O., Nacer-Laidi, H., Azmi, B., Fuller, C., Tut, G., … & Shallcross, L

16th December 2021

The Lancet Healthy Longevity

Prevalence and duration of detectable SARS-CoV-2 nucleocapsid antibodies in staff and residents of long-term care facilities over the first year of the pandemic (VIVALDI study): prospective cohort study in England

Krutikov M, Palmer T, Tut G, Fuller C, Azmi B, … Shallcross L

18th November 2021

Eurosurveillance

Changes in COVID-19 outbreak severity and duration in long-term care facilities following vaccine introduction, England, November 2020 to June 2021

Giddings R, Krutikov M, Palmer T, Fuller C, Azmi B, … Shallcross L

19th August 2021

The Lancet Healthy Longevity

Profile of humoral and cellular immune responses to single doses of BNT162b2 or ChAdOx1 nCoV-19 vaccines in residents and staff within residential care homes (VIVALDI): an observational study

Tut G, Lancaster T, Krutikov M, Sylla P, Bone D, Kaur N, … & Moss P

23rd June 2021

Lancet Infectious Diseases

Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort study

Shrotri M, Krutikov M, Palmer T, Giddings R, Azmi B, … Shallcross L

3rd June 2021

The Lancet Healthy Longevity

Incidence of SARS-CoV-2 infection according to baseline antibody status in staff and residents of 100 long-term care facilities (VIVALDI study): a prospective cohort study

Krutikov, M., Palmer, T., Tut, G., Fuller, C., Shrotri, M., … Shallcross, L

29th April 2021

New England Journal of Medicine

Spread of a Variant SARS-CoV-2 in Long-Term Care Facilities in England

Krutikov M, Hayward A, Shallcross L

11th February 2021

Lancet Healthy Longevity

Factors associated with SARS-CoV-2 infection and outbreaks in long-term care facilities in England: a national cross-sectional survey.

Shallcross, L., Burke, D., Abbott, O., Donaldson, A., Hallatt, G., … Thorne, S

29th January 2021

Wellcome Open Research

Study Protocol: Understanding SARS-Cov-2 infection, immunity and its duration in care home residents and staff in England (VIVALDI)

Krutikov M, Palmer T, Donaldson A, Lorencatto F, Forbes G, … Shallcross L

3rd July 2020

Office for National Statistics

Impact of coronavirus in care homes in England: 26 May to 19 June 2020

VIVALDI Home

About

Information for Care Homes

Archive

Engagement & Communication

In the Press/Publications

Participating Care Homes

Oversight & Governance

Partners

Frequently Asked Questions

Contact Us

In the Press/Publications

Loveday Abbey Road Enhances Care with VIVALDI

Infection Prevention and Control (IPC) Champion Network Meeting

Built Environment and SARS-CoV-2 Transmission in Long Term Care Facilities: Cross Sectional Survey and Data Linkage

VIVALDI Cohort Profile: Using linked, routinely collected data and longitudinal blood sampling to characterise COVID-19 infections, vaccinations, and related outcomes in care home staff and residents in England

COVID-19-related mortality and hospital admissions in the VIVALDI study cohort: October 2020 to March 2023

UKHSA launches new pilot to prevent care home infections

New UK Health Security Agency scheme to target infections in care homes

UKHSA announces pilot scheme to monitor infections in care homes in England

Pilot scheme to monitor infections announced

Care home network aims to reduce infections

Shaping care home COVID-19 testing policy: a protocol for a pragmatic cluster randomised controlled trial of asymptomatic testing compared with standard care in care home staff (VIVALDI-CT)

Effectiveness of successive booster vaccine doses against SARS-CoV-2 related mortality in residents of long-term care facilities in the VIVALDI study

Strong peak immunogenicity but rapid antibody waning following third vaccine dose in older residents of care homes

Clinical effectiveness of SARS-CoV-2 booster vaccine against Omicron infection in residents and staff of Long-Term Care Facilities: a prospective cohort study (VIVALDI)

Antibody and cellular immune responses following dual COVID-19 vaccination within infection-naïve residents of long-term care facilities: an observational cohort study

Duration of vaccine effectiveness against SARS-CoV2 infection, hospitalisation, and death in residents and staff of Long-Term Care Facilities (VIVALDI): a prospective cohort study

Robust SARS-CoV-2-specific and heterologous immune responses after natural infection in elderly residents of Long-Term Care Facilities

SARS-CoV-2 anti-spike antibody levels following second dose of ChAdOx1 nCov-19 or BNT162b2 in residents of long-term care facilities in England (VIVALDI)

Outcomes of SARS-CoV-2 Omicron infection in residents of long-term care facilities in England (VIVALDI): a prospective, cohort study

Prevalence and duration of detectable SARS-CoV-2 nucleocapsid antibodies in staff and residents of long-term care facilities over the first year of the pandemic (VIVALDI study): prospective cohort study in England

Changes in COVID-19 outbreak severity and duration in long-term care facilities following vaccine introduction, England, November 2020 to June 2021

Profile of humoral and cellular immune responses to single doses of BNT162b2 or ChAdOx1 nCoV-19 vaccines in residents and staff within residential care homes (VIVALDI): an observational study

Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort study

Incidence of SARS-CoV-2 infection according to baseline antibody status in staff and residents of 100 long-term care facilities (VIVALDI study): a prospective cohort study

Spread of a Variant SARS-CoV-2 in Long-Term Care Facilities in England

Factors associated with SARS-CoV-2 infection and outbreaks in long-term care facilities in England: a national cross-sectional survey.

Study Protocol: Understanding SARS-Cov-2 infection, immunity and its duration in care home residents and staff in England (VIVALDI)

Impact of coronavirus in care homes in England: 26 May to 19 June 2020

Email

Pages

Subscribe

Privacy & Data